144 related articles for article (PubMed ID: 1419619)
21. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure.
Sallie R; Katsiyiannakis L; Baldwin D; Davies S; O'Grady J; Mowat A; Mieli-Vergani G; Williams R
Hepatology; 1992 Nov; 16(5):1206-11. PubMed ID: 1427659
[TBL] [Abstract][Full Text] [Related]
22. Severe Elevation of Liver Tests in Choledocholithiasis: An Uncommon Occurrence With Important Clinical Implications.
Bangaru S; Thiele D; Sreenarasimhaiah J; Agrawal D
J Clin Gastroenterol; 2017 Sep; 51(8):728-733. PubMed ID: 27466169
[TBL] [Abstract][Full Text] [Related]
23. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.
Kozic JR; Benton SJ; Hutcheon JA; Payne BA; Magee LA; von Dadelszen P;
J Obstet Gynaecol Can; 2011 Oct; 33(10):995-1004. PubMed ID: 22014776
[TBL] [Abstract][Full Text] [Related]
24. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
[TBL] [Abstract][Full Text] [Related]
25. Changes in the clearance of total and unbound etoposide in patients with liver dysfunction.
Stewart CF; Arbuck SG; Fleming RA; Evans WE
J Clin Oncol; 1990 Nov; 8(11):1874-9. PubMed ID: 2230875
[TBL] [Abstract][Full Text] [Related]
26. Liver function tests in metastatic uveal melanoma.
Kaiserman I; Amer R; Pe'er J
Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
[TBL] [Abstract][Full Text] [Related]
27. Phase 1 and pharmacokinetic study of intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction.
Schaaf LJ; Hammond LA; Tipping SJ; Goldberg RM; Goel R; Kuhn JG; Miller LL; Compton LD; Cisar LA; Elfring GL; Gruia G; McGovren JP; Pirotta N; Yin D; Sharma A; Duncan BA; Rothenberg ML
Clin Cancer Res; 2006 Jun; 12(12):3782-91. PubMed ID: 16778106
[TBL] [Abstract][Full Text] [Related]
28. Cryoprotective therapy for hepatocellular carcinoma: study of 51 patients with a single lesion.
Ali AM; Lizhi N; Jialiang L; Fei Y; Yuan W; Jianying Z; Jin Y; Jibing C; Feng M; Kecheng X
Cryobiology; 2014 Aug; 69(1):61-7. PubMed ID: 24859156
[TBL] [Abstract][Full Text] [Related]
29. Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer.
Jakobsen P; Steiness E; Bastholt L; Dalmark M; Lorenzen A; Petersen D; Gjedde SB; Sandberg E; Rose C; Nielsen OS
Cancer Chemother Pharmacol; 1991; 28(1):63-8. PubMed ID: 2040035
[TBL] [Abstract][Full Text] [Related]
30. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
[TBL] [Abstract][Full Text] [Related]
31. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
[TBL] [Abstract][Full Text] [Related]
32. Predicting acute liver failure in dengue infection.
Kumarasena RS; Niriella MA; Ranawaka CK; Miththinda JK; de Silva AP; Dassanayaka AS; de Silva HJ
Ceylon Med J; 2016 Mar; 61(1):35-6. PubMed ID: 27031978
[TBL] [Abstract][Full Text] [Related]
33. Role of liver function enzymes in diagnosis of choledocholithiasis in biliary colic patients.
Zare M; Kargar S; Akhondi M; Mirshamsi MH
Acta Med Iran; 2011; 49(10):663-6. PubMed ID: 22071641
[TBL] [Abstract][Full Text] [Related]
34. Etoposide pharmacokinetics in patients with normal and abnormal organ function.
Arbuck SG; Douglass HO; Crom WR; Goodwin P; Silk Y; Cooper C; Evans WE
J Clin Oncol; 1986 Nov; 4(11):1690-5. PubMed ID: 3772420
[TBL] [Abstract][Full Text] [Related]
35. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
[TBL] [Abstract][Full Text] [Related]
36. Cryoprotective therapy for huge hepatocellular carcinoma: a study of 14 patients with a single lesion.
Alnaggar M; Niu L; Li J; Yao F; Wang Y; Zeng J; Ye J; Chen J; Mu F; Xu K
Cryobiology; 2014 Dec; 69(3):457-61. PubMed ID: 25445461
[TBL] [Abstract][Full Text] [Related]
37. Epirubicin. Clinical pharmacology and dose-effect relationship.
Robert J
Drugs; 1993; 45 Suppl 2():20-30. PubMed ID: 7693418
[TBL] [Abstract][Full Text] [Related]
38. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
[TBL] [Abstract][Full Text] [Related]
39. Significance of low or normal serum gamma glutamyl transferase level in infants with idiopathic neonatal hepatitis.
Wang JS; Tan N; Dhawan A
Eur J Pediatr; 2006 Nov; 165(11):795-801. PubMed ID: 16770572
[TBL] [Abstract][Full Text] [Related]
40. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
